1431542-16-3 Usage
Chemical structure
The compound consists of a piperazine ring attached to an ethanone group, with a 5-bromo-2-methylbenzoyl moiety at the 4-position of the piperazine ring.
Molecular weight
Approximately 365.28 g/mol (based on the molecular formula)
Appearance
The compound is likely to be a solid, given its molecular weight and structure
Pharmaceutical research
1-[4-(5-bromo-2-methylbenzoyl)-1-piperazinyl]ethanone is often used in pharmaceutical research and development due to its potential pharmacological properties.
Potential applications
The compound may have applications as a potential drug candidate for various medical conditions, including psychiatric disorders and neurological diseases.
Drug interactions
Its unique structure and chemical properties make it a valuable tool for studying drug interactions and mechanisms of action within the body.
Drug discovery and design
The compound's potential role in drug discovery and design makes it a significant chemical of interest in the pharmaceutical industry.
Solubility
The solubility of the compound in various solvents (e.g., water, organic solvents) may vary depending on its specific functional groups and molecular interactions.
Stability
The stability of the compound under different conditions (e.g., temperature, pH, light exposure) may impact its suitability for pharmaceutical applications.
Synthesis
The compound can be synthesized through various chemical reactions, involving the formation of the piperazine ring, attachment of the ethanone group, and introduction of the 5-bromo-2-methylbenzoyl moiety.
Purity
The purity of the compound is essential for its effectiveness and safety in pharmaceutical applications, and it can be determined through analytical techniques such as high-performance liquid chromatography (HPLC) or mass spectrometry.
Toxicity
The toxicity of the compound should be evaluated to ensure its safety for potential pharmaceutical applications, including acute and chronic toxicity studies.
Metabolism
Understanding the metabolic pathways and metabolites of the compound can provide insights into its pharmacokinetics, pharmacodynamics, and potential drug-drug interactions.
Patent status
The patent status of the compound may impact its development and commercialization, as well as its availability for research purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 1431542-16-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,1,5,4 and 2 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1431542-16:
(9*1)+(8*4)+(7*3)+(6*1)+(5*5)+(4*4)+(3*2)+(2*1)+(1*6)=123
123 % 10 = 3
So 1431542-16-3 is a valid CAS Registry Number.
1431542-16-3Relevant articles and documents
Use of Inhibitors of the Activity or Function of PI3K
-
Paragraph 0845-0846, (2016/01/09)
The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.
Use of inhibitors of the activity or function of PI3K
-
Page/Page column 93, (2013/07/05)
The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.
